Has Shahram Majidi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $208,441 in general payments to Shahram Majidi, MD across 273 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Shahram Majidi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Shahram Majidi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Shahram Majidi, MD

Neurological Surgery · New York, NYNPI 1073956264

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (54.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Medical Device Business Services, Inc. at 42.1% of the total. 2025 is the largest year on record at $101,255, more than ten times the $571 reported in 2019. Among neurological surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$208,441in general payments, 2019–2025

Across 273 payments — averaging $763.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medical Device Business Services, Inc.$88K
Rapid Medical Ltd$57K
Imperative Care, Inc$55K
Stryker$2K
Microvention, Inc.$2K
Johnson & Johnson$1K
plus $4K from 12 others

$919,037in research payments, 2019–2025

Across 88 payments — averaging $10,444 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Imperative Care, Inc$772K
Stryker$67K
Microvention, Inc.$44K
Medical Device Business Services, Inc.$35K
Siemens Medical Solutions USA, Inc.$750
Rapid Medical Ltd$390

What the payments were for

Consulting fees$114,51155%
Travel & lodging$64,86131%
Food & beverage$29,06914%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medical Device Business Services, Inc.	75	$87,722
Rapid Medical Ltd	41	$56,663
Imperative Care, Inc	71	$54,905
Stryker	34	$2,288
Microvention, Inc.	9	$1,841
Johnson & Johnson	16	$1,265
Depuy Synthes Products, Inc.	2	$900
Medtronic(2 entities)	5	$786
Penumbra, Inc.	8	$432
BD	1	$362
Balt USA, LLC	2	$293
Route 92 Medical, Inc.	1	$261
Phenox Inc.	1	$175
AstraZeneca	2	$143
Asahi Intecc USA, Inc.	2	$115
Genentech USA, Inc.	1	$114
Biosense Webster, Inc.	1	$109
Genentech, Inc.	1	$66

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

EMBOGUARD$57,284
COMANECI 17$55,858
TIGERTRIEVER 17 REVASCULARIZATION DEVICE$55,858
ZOOM 88-T LARGE DISTAL PLATFORM$52,728
TRUFILL$5,551
Pulsar Vascular PulseRider Aneurysm Neck Reconstruction Device$4,726
STENT$1,621
WEB Aneurysm Embolization System$1,324
CEREPAK UNIFORM$1,042
ZOOM REPERFUSION CATHETER$1,025
SPOTLIGHT$900
TARGET$485
SURPASS EVOLVE$464
SURPASS$460
PULSERIDER$420
CEREBASE$353
8F Base Camp Sheath System$261
Jet 7$203
SOFIA 6F-131CM STR$190
Avenir Coil$175

How this compares

$208,441 in reported general payments places this provider in the 90th percentile of 446 neurological surgery providers in New York.

See all neurological surgery providers in New York →

Medicare billing

Part B allowed, 2024

$118,086

Medicare patients

107

Services billed

395

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurological surgery in New York

J MoccoNew York$1.6M
Alejandro BerensteinNew York$1.1M
Darryl LauNew York$915K
Mark BilskyNew York$903K
Jan-Karl BurkhardtNew York$441K
Dean ChouNew York$383K
Reade DeleacyNew York$329K
Johanna FifiNew York$326K
David LangerNew York$258K
Ali BaajNew York$240K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →